Morphic Therapeutic
MORF
$27.69
Share price
-3.69%
Change (1 day)
-36.39%
Change (1 year)
Categories
Earnings for Morphic Therapeutic (MORF)
Earnings in 2023 (TTM): -$0.18 B
According to Morphic Therapeutic's latest financial reports the company's current earnings (TTM) are -$0.18 B. In 2022 the company made an earning of -$63.4 M an increase over its 2021 earnings that were of -$95.81 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Morphic Therapeutic from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.18 B | 181.86% |
| 2022 | -$63.4 M | -33.83% |
| 2021 | -$95.81 M | 103.07% |
| 2020 | -$47.18 M | 0.41% |
| 2019 | -$46.99 M | 90.79% |
| 2018 | -$24.63 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.19 B | 3.15% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$18.95 M | -89.40% | 🇺🇸 USA |